AF
IDXG

Allworth Financial’s Interpace Biosciences, Inc. Common Stock IDXG Stock Holding History

Allworth Financial’s Portfolio IDXG Stock Details IDXG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q1 		– Sell
-1,429
Closed -$4K – 1674
2020
Q4 		$4K Hold
1,429
– – ﹤0.01% 1056
2020
Q3 		$4K Hold
1,429
– – ﹤0.01% 902
2020
Q2 		$7K Hold
1,429
– – ﹤0.01% 813
2020
Q1 		$7K Hold
1,429
– – ﹤0.01% 813
2019
Q4 		$7K Hold
1,429
– – ﹤0.01% 719
2019
Q3 		$11K Buy
+1,429
New +$11.2K ﹤0.01% 574

Other funds holding IDXG

HF
HRT Financial New York $54.8B AUM 81.03% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
TRCT
Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

Allworth Financial's IDXG Position: Q1 2021 in Review

Allworth Financial sold out of Interpace Biosciences, Inc. Common Stock (IDXG) in Q1 2021, closing a stake of 1,429 shares — an estimated $4K sold.

Allworth Financial first reported a position in IDXG in Q3 2019 and held it in 6 quarters. The position peaked at $11K in Q3 2019. 3 funds tracked by Wall St. Rank hold IDXG as of Q1 2021.

  • Allworth Financial reported no remaining Interpace Biosciences, Inc. Common Stock position as of Q1 2021 after selling out during the quarter.
  • Allworth Financial sold 1,429 Interpace Biosciences, Inc. Common Stock shares in Q1 2021, an estimated $4K.
  • Allworth Financial first reported a position in Interpace Biosciences, Inc. Common Stock in Q3 2019 and held it in 6 quarters.
  • Allworth Financial's Interpace Biosciences, Inc. Common Stock position peaked at $11K in Q3 2019.
  • 3 funds tracked by Wall St. Rank held Interpace Biosciences, Inc. Common Stock as of Q1 2021.

Based on Allworth Financial's 13F filing for Q1 2021, filed 29 Apr 2021.